Levothyroxine Sodium
- Product NDC
- 50436-5501
- 11-digit product format
- 504365501
- Labeler code
- 50436
- Product ID
- 50436-5501_16626b29-36c7-4fd9-949e-65cbcef62728
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Levothyroxine Sodium
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Unit Dose Services
- Application
- NDA021210
- Marketing category
- NDA
- Marketing start
- 2003-12-01
- Marketing end
- 0000-00-00
- Substance
- LEVOTHYROXINE SODIUM ANHYDROUS
- Active strength
- 0 mg/1
- Pharmacologic classes
- l-Thyroxine [EPC],Thyroxine [CS]
- NDC exclude flag
- No
- Listing certified through
- 2019-12-31
- Current FDA listing
- Historical FDA.report record
NDC auxiliary status#
Explicit status records from FDA unfinished, excluded, and compounder auxiliary files. Absence of a row is not itself a regulatory status. Browse every current auxiliary row, including rows without a usable NDC. · Browse every captured source and parsed snapshot.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded product | product | 50436-5501 | I | Inactivated by FDA | 2026-07-31 | ||
| excluded package | package | 50436-5501 | 50436-5501-2 | I | Inactivated by FDA | 2026-07-31 | |
| excluded package | package | 50436-5501 | 50436-5501-3 | I | Inactivated by FDA | 2026-07-31 |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N021210-001 | UNITHROID | LEVOTHYROXINE SODIUM | 0.025MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | RLD | 2000-08-21 |
| N021210-002 | UNITHROID | LEVOTHYROXINE SODIUM | 0.05MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | RLD | 2000-08-21 |
| N021210-003 | UNITHROID | LEVOTHYROXINE SODIUM | 0.075MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | RLD | 2000-08-21 |
| N021210-004 | UNITHROID | LEVOTHYROXINE SODIUM | 0.088MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | RLD | 2000-08-21 |
| N021210-005 | UNITHROID | LEVOTHYROXINE SODIUM | 0.1MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | RLD | 2000-08-21 |
| N021210-006 | UNITHROID | LEVOTHYROXINE SODIUM | 0.112MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | RLD | 2000-08-21 |
| N021210-007 | UNITHROID | LEVOTHYROXINE SODIUM | 0.125MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | RLD | 2000-08-21 |
| N021210-008 | UNITHROID | LEVOTHYROXINE SODIUM | 0.15MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | RLD | 2000-08-21 |
| N021210-009 | UNITHROID | LEVOTHYROXINE SODIUM | 0.175MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | RLD | 2000-08-21 |
| N021210-010 | UNITHROID | LEVOTHYROXINE SODIUM | 0.2MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | RLD | 2000-08-21 |
| N021210-011 | UNITHROID | LEVOTHYROXINE SODIUM | 0.3MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | RLD, RS | 2000-08-21 |
| N021210-012 | UNITHROID | LEVOTHYROXINE SODIUM | 0.137MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | RLD | 2008-02-08 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| N021210-001 | AB1 |
| N021210-001 | AB2 |
| N021210-001 | AB3 |
| N021210-002 | AB1 |
| N021210-002 | AB2 |
| N021210-002 | AB3 |
| N021210-003 | AB1 |
| N021210-003 | AB2 |
| N021210-003 | AB3 |
| N021210-004 | AB1 |
| N021210-004 | AB2 |
| N021210-004 | AB3 |
| N021210-005 | AB1 |
| N021210-005 | AB2 |
| N021210-005 | AB3 |
| N021210-006 | AB1 |
| N021210-006 | AB2 |
| N021210-006 | AB3 |
| N021210-007 | AB1 |
| N021210-007 | AB2 |
| N021210-007 | AB3 |
| N021210-008 | AB1 |
| N021210-008 | AB2 |
| N021210-008 | AB3 |
| N021210-009 | AB1 |
| N021210-009 | AB2 |
| N021210-009 | AB3 |
| N021210-010 | AB1 |
| N021210-010 | AB2 |
| N021210-010 | AB3 |
| N021210-011 | AB1 |
| N021210-011 | AB2 |
| N021210-011 | AB3 |
| N021210-012 | AB1 |
| N021210-012 | AB2 |
| N021210-012 | AB3 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | N021210-001 | UNITHROID | 0.025MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | RLD | 2000-08-21 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | N021210-002 | UNITHROID | 0.05MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | RLD | 2000-08-21 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | N021210-003 | UNITHROID | 0.075MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | RLD | 2000-08-21 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | N021210-004 | UNITHROID | 0.088MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | RLD | 2000-08-21 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | N021210-005 | UNITHROID | 0.1MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | RLD | 2000-08-21 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | N021210-006 | UNITHROID | 0.112MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | RLD | 2000-08-21 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | N021210-007 | UNITHROID | 0.125MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | RLD | 2000-08-21 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | N021210-008 | UNITHROID | 0.15MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | RLD | 2000-08-21 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | N021210-009 | UNITHROID | 0.175MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | RLD | 2000-08-21 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | N021210-010 | UNITHROID | 0.2MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | RLD | 2000-08-21 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | N021210-011 | UNITHROID | 0.3MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | RLD, RS | 2000-08-21 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | N021210-012 | UNITHROID | 0.137MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | RLD | 2008-02-08 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | N021210-001 | AB1 | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | N021210-001 | AB2 | 2 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | N021210-001 | AB3 | 3 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | N021210-002 | AB1 | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | N021210-002 | AB2 | 2 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | N021210-002 | AB3 | 3 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | N021210-003 | AB1 | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | N021210-003 | AB2 | 2 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | N021210-003 | AB3 | 3 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | N021210-004 | AB1 | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | N021210-004 | AB2 | 2 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | N021210-004 | AB3 | 3 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | N021210-005 | AB1 | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | N021210-005 | AB2 | 2 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | N021210-005 | AB3 | 3 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | N021210-006 | AB1 | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | N021210-006 | AB2 | 2 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | N021210-006 | AB3 | 3 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | N021210-007 | AB1 | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | N021210-007 | AB2 | 2 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | N021210-007 | AB3 | 3 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | N021210-008 | AB1 | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | N021210-008 | AB2 | 2 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | N021210-008 | AB3 | 3 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | N021210-009 | AB1 | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | N021210-009 | AB2 | 2 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | N021210-009 | AB3 | 3 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | N021210-010 | AB1 | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | N021210-010 | AB2 | 2 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | N021210-010 | AB3 | 3 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | N021210-011 | AB1 | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | N021210-011 | AB2 | 2 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | N021210-011 | AB3 | 3 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | N021210-012 | AB1 | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | N021210-012 | AB2 | 2 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | N021210-012 | AB3 | 3 | a50c72e98297… |
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | NCS HealthCare of KY, LLC dba Vangard Labs | abe173cc-1579-43a5-b12d-a31958d0a539 | 2026-06-04 | Boxed warning, Warnings, Adverse reactions | 021210 NDA021210 |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Northwind Health Company, LLC | c968836a-f94c-4d13-e053-2995a90a8df5 | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | 021210 NDA021210 |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Amneal Pharmaceuticals NY LLC | fca88c97-5cd4-4834-ba87-deb5bd637788 | 2024-12-06 | Boxed warning, Warnings, Adverse reactions | 021210 NDA021210 |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Proficient Rx LP | 2f0657d5-3e5c-4249-bfaa-7f5ef1528672 | 2021-01-01 | Boxed warning, Warnings, Adverse reactions | 021210 NDA021210 |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Proficient Rx LP | 97e28b00-9913-463f-9de2-08c828edbe67 | 2020-03-01 | Boxed warning, Warnings, Adverse reactions | 021210 NDA021210 |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Proficient Rx LP | 05ab038e-45fa-488e-a05e-12a2dd3564c1 | 2020-01-01 | Boxed warning, Warnings, Adverse reactions | 021210 NDA021210 |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Proficient Rx LP | b81720f9-2836-4c1d-8691-0f6acef13316 | 2020-01-01 | Boxed warning, Warnings, Adverse reactions | 021210 NDA021210 |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Proficient Rx LP | 434075d5-a82b-4f17-85e6-4c1922663dbc | 2019-10-01 | Boxed warning, Warnings, Adverse reactions | 021210 NDA021210 |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Proficient Rx LP | 18c7c63a-642e-47fe-a8ee-12aaf652b2aa | 2019-10-01 | Boxed warning, Warnings, Adverse reactions | 021210 NDA021210 |
| Unithroid | LEVOTHYROXINE SODIUM | Amneal Pharmaceuticals LLC | 07562e72-7eaa-4ce6-94f0-e08814787e50 | 2019-06-19 | Boxed warning, Warnings, Adverse reactions | 021210 NDA021210 |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 97c252d3-9bb8-4530-bb44-9824dc7cf556 | Product name | 6 | 20250729 |
| 6c43b71c-35e6-4db3-ba24-c6ef42ff7003 | Product name | 3 | 20240207 |
| 890fd4bf-1a80-42b7-be1b-2d0259d5f0c8 | Product name | 5 | 20240207 |
| c8ad26bf-af73-460b-b74e-1eff16cc4f9f | Product name | 5 | 20240207 |
| 01383843-4069-43cf-aa76-dc17a6f9f8c4 | Product name | 2 | 20230123 |
| 978cca7d-a938-4791-8322-da48d90a63ef | Product name | 1 | 20230113 |
| 65f86ba3-8816-4e12-899b-18290c8de551 | Product name | 2 | 20210614 |
| f16ab90f-08c2-40be-a543-66d9827cd1f3 | Product name | 1 | 20210601 |
| 6a33ec05-2ae2-45e5-ab82-2d94b3303923 | Product name | 1 | 20190709 |
| 93355a10-1c44-4c92-a11d-7d995e0200d9 | Product name | 1 | 20190219 |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 50436-5501-2 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-0028-f424-e053-dadaa90a57ce | Levothyroxine Sodium Tablets, USP |
| 50436-5501-3 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-0028-f424-e053-dadaa90a57ce | Levothyroxine Sodium Tablets, USP |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 50436-5501-2 | Levothyroxine Sodium | 30 in 1 BOTTLE | TABLET | 30 | 2 | |
| 50436-5501-3 | Levothyroxine Sodium | 90 in 1 BOTTLE | TABLET | 90 | 2 |
DailyMed Socrata Ingredients#
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 50436-5501 | LEVOTHYROXINE SODIUM TABLET [UNIT DOSE SERVICES] | 2 | Legacy NDC, 2 package rows | 20131007_ac83ac72-b447-47df-b6ad-94537305b7b8.zip |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 966248 | levothyroxine sodium 112 MCG Oral Tablet | PSN | ac83ac72-b447-47df-b6ad-94537305b7b8 | 2 |
| 966248 | levothyroxine sodium 0.112 MG Oral Tablet | SCD | ac83ac72-b447-47df-b6ad-94537305b7b8 | 2 |
| 966248 | levothyroxine sodium 112 MCG Oral Tablet | SY | ac83ac72-b447-47df-b6ad-94537305b7b8 | 2 |
Packages#
| Package NDC | 11-digit format | Description | Status |
|---|---|---|---|
| 50436-5501-2 | 50436550102 | 30 in 1 BOTTLE | Historical |
| 50436-5501-3 | 50436550103 | 90 in 1 BOTTLE | Historical |